CS

Channenahalli Shankarappa Kirankumar

Active Director Managing Director DIN 11701641
DIN 11701641 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Channenahalli Shankarappa Kirankumar

Data last updated:

Channenahalli Shankarappa Kirankumar is a Managing Director at Ackomed Pharma Private Limited (since 2026).

DIN 11701641
Primary Designation Managing Director
First Appointment 09 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ackomed Pharma Private Limited U46497KA2026PTC220537
Managing Director09 May 20262026Active

Board colleagues of Channenahalli Shankarappa Kirankumar

NameDINCompanyDesignation
Sanjeevarayappa Santhosh Kumar11701647Ackomed Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ackomed Pharma Private Limited
Premium access

Shareholding and investment profile for Channenahalli Shankarappa Kirankumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Channenahalli Shankarappa Kirankumar

Channenahalli Shankarappa Kirankumar currently holds 1 directorship: Ackomed Pharma Private Limited (Managing Director, since 09 May 2026).

Channenahalli Shankarappa Kirankumar was first appointed on 09 May 2026 as Managing Director at Ackomed Pharma Private Limited.

The current boards of Channenahalli Shankarappa Kirankumar's companies include Sanjeevarayappa Santhosh Kumar (Ackomed Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available